Increased tumor necrosis factor-α and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: The effects of analgesic drugs

Anesthesia and Analgesia

Volumn 104, Issue 4, 2007, Pages 949-954

  Bianchi, Mauro ^a,b   Martucci, Cataldo ^a   Ferrario, Paolo ^a   Franchi, Silvia ^a   Sacerdote, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Department of Pharmacology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; NIMESULIDE; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; PROSTAGLANDIN E; SODIUM CHLORIDE; TRAMADOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FREUND'S ADJUVANT; HYPERALGESIA; INFLAMMATION; MALE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; TOUCH; TRAMADOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34047266964     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000258060.89380.27     Document Type: Article

References (37)

1. Bianchi M, Panerai AE. Effects of lornoxicam, piroxicam and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail. Pharmacol Res 2002;45:101-15.
2. Bianchi M, Martucci C, Biella G, et al. Increased substance P and tumor necrosis factor-α level in the paws following formalin injection in rat tail. Brain Res 2004;1019:255-8.
3. Raghavendra V, Tanga FY, DeLeo JA. Complete Freunds adjuvant - induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 2004;20:467-73.
4. Bianchi M, Broggini M. Anti-hyperalgesic effects of nimesulide: studies in rats and humans. Int J Clin Pract 2002;128 (Suppl):11-19.
5. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-8.
6. Bianchi M, Panerai AE. The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br J Pharmacol 1996;117:130-2.
7. Bianchi M, Panerai AE. Anti-hyperalgesic effects of tramadol in the rat. Brain Res 1998;797:163-6.
8. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002;42:553-83.
9. McMahon S, Cafferty WBJ, Marchand F. Immune glial cell factors as pain mediators and modulators. Exp Neurol 2005;192:444-62.
10. Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Int Med 2005;257:139-55.
11. Baba H, Kohno T, Moore KA, Woolf CJ. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 2001;21:1750-6.
12. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5.
13. Reeve AJ, Patel S, Fox A, et al. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 2002;4:247-57.
14. Onda A, Hamba M, Yabuki S, Kikuchi S. Exogenous tumor necrosis factor-α induces abnormal discharges in rat dorsal horn neurons. Spine 2002;27:1618-24.
15. Milligan ED, O'Connor KA, Nguyen KT, et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 2001;21:2808-19.
16. Kwon MS, Shim EJ, Seo YJ, et al. Differential modulatory effect of cholera toxin and pertussis toxin on pain behavior induced by TNF-α, interleukin-1β and interferon-γ injected intrathecally. Arch Pharm Res 2005;28:582-6.
17. Bennett A, Villa G. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Expert Opin Pharmacother 2000;1:277-86.
18. McClellan K, Scott LJ. Tramadol/Paracetamol. Drugs 2003;63:1079-86.
19. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005;12:46-55.
20. Fricke JR Jr, Hewitt DJ, Jordan DM, et al. A double-blind placebo-controlled comparison of tramadol/acetaminophen and tramadol in patients with postoperative dental pain. Pain 2004;109:250-7.
21. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 1983;16:109-10.
22. Stein C, Millan MJ, Herz A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 1988;31:445-51.
23. Sorkin LS, Moore JH. Evoked release of amino acids and prostanoids in spinal cord of anesthetized rats: changes during peripheral inflammation and hyperalgesia. Am J Ther 1996;3:268-75.
24. Hay CH, Trevethick MA, Wheeldon A, et al. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience 1997;78:843-50.
25. 2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain 2001;92:213-18.
26. Muth-Selbach US, Tegeder I, Brune K, Geisslinger G. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology 1999;91:231-9.
27. 2 release by flurbiprofen enantiomers: a microdialysis study. J Neurochem 2000;74:2094-100.
28. Buccellati C, Sala A, Ballerio R, Bianchi M. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglanding endoperoxide synthases. Eur J Pain 2000;4:413-15.
29. Raffa RB, Friderichs E, Reimann W, et al. Opioid and non opioid components independently contribute to the mechanisms of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85.
30. Dayer P, Collar L, Desmeules J. The pharmacology of tramadol. Drugs 1994;47:3-7.
31. Stein C, Schafer M, Machelska H. Attacking pain at its source: new perspective on opioids. Nat Med 2003;9:1003-8.
32. Bianchi M, Panerai AE. Antidepressant drugs and experimental inflammation. Pharmacol Res 1996;33:235-8.
33. Bianchi M, Rossoni G, Sacerdote P, Panerai AE. Effects of tramadol on experimental inflammation. Fundam Clin Pharmacol 1999;13:220-5.
34. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmuneactivation in persistent pain. Pain 2001;90:1-6.
35. Milligan ED, Langer SJ, Sloane EM, et al. Controlling pathological pain by adenovirally driven spinal production of the antiinflammatory cytokine, interleukin-10. Eur J Neurosci 2005;21:2136-48.
36. Ledeboer A, Sloane EM, Milligan ED, et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005;115:71-83.
37. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2003;2:973-85.